Inhibition of methaemoglobin reduction by sodium salicylate.
D002463:Cell Membrane Permeability / Q000187:drug effects; D008058:Dihydrolipoamide Dehydrogenase / Q000037:antagonists & inhibitors; D004912:Erythrocytes / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008706:Methemoglobin / Q000032:analysis; D009243:NAD / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D012980:Sodium Salicylate / Q000378:metabolism / Q000494:pharmacology*; D013057:Spectrum Analysis
D009243:NAD; D008706:Methemoglobin; D012964:Sodium; D008058:Dihydrolipoamide Dehydrogenase; D011188:Potassium; D012980:Sodium Salicylate